Ireland consults on supply of medicines for companion animals
This article was originally published in SRA
The Irish Medicines Board is reviewing the suitability of existing methods of supplying veterinary anthelmintics and antiparasitic medicines intended for use in companion animals1. The IMB notes that the fact that there are various ways in which such medicines can be supplied has led to differing opinions amongst stakeholders on which route is the most suitable.
You may also be interested in...
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.